European Biosimilars Congress

7th European Biosimilars Congress 2017 Organizing Committee invites you to attend the largest assemblage of biologics and biosimilars researchers from around the globe during May 15-17, 2017 at Munich, Germany.

European Biosimilars Congress is a global annual event. This European Biosimilars Congress 2017 will bring together scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials and CROs from around the world. The passage of biosimilars through a decade at Europe finds much requirement for discussion also focussing the latest developments in the field of biologics and biosimilars. A comprehensive approach for the discussion has been taken up as listed below under several tracks and sub-tracks below:

1. Current Challenges of Biologics
2. Emerging Biosimilars in Therapeutics
3. Analytical Strategies for Biosimilars
4. Regulatory Approach and Legal Issues of Biosimilars
5. Innovative Approach for Biosimilars
6. Consequences of Brexit on Biosimilars
7. Globalization of Biosimilars
8. Clinical Development of Biosimilars
9. Biosimilar Market and Cost Analysis
10. Pharmacovigilance on Biosimilars